US EditionDual Immunotherapy Approved for Mexicans with Advanced Melanoma
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Staff/RG It is estimated that more than 2,000 Mexicans live with melanoma , the most dangerous skin cancer . Unfortunately, 8 out of 10 cases are diagnosed in advanced stages In order to offer new treatment options that give hope to patients, the combination of two Bristol Myers Squibb immunotherapies for adults and children over 12 years of age with unresectable or metastatic melanoma was authorized in Mexico .
It is estimated that more than 2,000 Mexicans live with melanoma, the most dangerous skin cancer. Unfortunately, 8 out of 10 cases are diagnosed in advanced stages. Mexico City.- Bristol Myers Squibb biopharmaceutical (BMS) Mexico announced that it received authorization for a drug that combines two immunotherapies for the treatment of adults and children over 12 years of age with unresectable or metastatic melanoma; that is, that it cannot be r…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium
